SDGR

Schrodinger Inc. (SDGR) is a leading innovator in computational drug design, distinguished by its advanced physics-based software platform that accelerates the discovery and optimization of novel molecules for the pharmaceutical and materials science sectors. Based in New York, Schrodinger leverages state-of-the-art computational methodologies to enhance drug development processes, significantly reducing both the time and costs associated with bringing new therapeutics to market. By empowering biotech and pharmaceutical companies to refine their research and development capabilities, Schrodinger has established itself as a vital player at the intersection of software technology and life sciences, well-positioned to tackle the intricate challenges of drug discovery.